Piotr Skalij

Direct Oral Anticoagulants in Cancer Patients. Time for a Change in Paradigm

S. Tucker, K. Honn, M. Wojtukiewicz, 2020, Cancers.

Nadroparin in the prophylaxis and treatment of thromboembolic complications in cancer patients

M. Wojtukiewicz, Piotr Skalij, P. Tokajuk, 2016 .

TAS-102 – a new option in the treatment of patients with advanced colorectal cancer after failure or intolerance to other therapies

M. Wojtukiewicz, Piotr Skalij, P. Tokajuk, 2020, OncoReview.

Long-term disease control during TAS-102 therapy in the VI line treatment in a 73-year-old mCRC patient. A case report

M. Wojtukiewicz, Piotr Skalij, P. Tokajuk, 2020, OncoReview.

Granulocyte-Colony Stimulating Factor Receptor, Tissue Factor, and VEGF-R Bound VEGF in Human Breast Cancer In Loco.

M. Wojtukiewicz, E. Sierko, P. Thorpe, 2016, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Pain management during radiotherapy and radiochemotherapy in oropharyngeal cancer patients: single-institution experience.

M. Wojtukiewicz, E. Sierko, Monika Konopka-Filippow, 2015, International dental journal.

It is not just the drugs that matter: the nocebo effect

K. Honn, M. Wojtukiewicz, Piotr Skalij, 2019, Cancer and Metastasis Reviews.